Home Biosimilar Antibodies Neuronal Signaling Beta Amyloid antibody Crenezumab (Anti-Amyloid Beta) For research use only.
Not for use in humans.

Crenezumab (Anti-Amyloid Beta)

Synonyms: MABT 5102A; RG 7412

Crenezumab (Anti-Amyloid Beta) is a fully humanized  immunoglobulin (Ig) G4 monoclonal antibody that targets amyloid beta (Abeta) with potential for use in Alzheimer's disease research. MW: 143.58 kD.

Crenezumab (Anti-Amyloid Beta)

Purity & Quality Control

≥99

Choose Selective Beta Amyloid Inhibitors

Biological Activity

Description Crenezumab (Anti-Amyloid Beta) is a fully humanized  immunoglobulin (Ig) G4 monoclonal antibody that targets amyloid beta (Abeta) with potential for use in Alzheimer's disease research. MW: 143.58 kD.

Product Details

CAS No. 1095207-05-8
Molecular Weight 143.58
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Crenezumab (Anti-Amyloid Beta) | Crenezumab (Anti-Amyloid Beta) supplier | purchase Crenezumab (Anti-Amyloid Beta) | Crenezumab (Anti-Amyloid Beta) cost | Crenezumab (Anti-Amyloid Beta) manufacturer | order Crenezumab (Anti-Amyloid Beta) | Crenezumab (Anti-Amyloid Beta) distributor